ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 70 filers reported holding ANTARES PHARMA INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $296,758 | -9.8% | 72,380 | -21.5% | 0.00% | – |
Q4 2021 | $329,000 | -2.4% | 92,174 | -0.4% | 0.00% | – |
Q3 2021 | $337,000 | -21.3% | 92,547 | -5.8% | 0.00% | – |
Q2 2021 | $428,000 | +8.1% | 98,261 | +1.9% | 0.00% | – |
Q1 2021 | $396,000 | -0.8% | 96,448 | -3.5% | 0.00% | – |
Q4 2020 | $399,000 | +47.8% | 99,992 | -0.1% | 0.00% | – |
Q3 2020 | $270,000 | +0.4% | 100,130 | 0.0% | 0.00% | – |
Q2 2020 | $269,000 | +8.5% | 100,130 | -4.5% | 0.00% | – |
Q1 2020 | $248,000 | -46.3% | 104,883 | +6.7% | 0.00% | – |
Q4 2019 | $462,000 | +29.1% | 98,300 | -5.2% | 0.00% | – |
Q3 2019 | $358,000 | +4.7% | 103,643 | -0.4% | 0.00% | – |
Q2 2019 | $342,000 | +15.9% | 104,068 | +7.0% | 0.00% | – |
Q1 2019 | $295,000 | +4.6% | 97,234 | -6.5% | 0.00% | – |
Q4 2018 | $282,000 | +89.3% | 104,012 | +133.8% | 0.00% | – |
Q3 2018 | $149,000 | -51.3% | 44,487 | -62.5% | 0.00% | – |
Q2 2018 | $306,000 | +19.5% | 118,707 | +2.4% | 0.00% | – |
Q1 2018 | $256,000 | +8.0% | 115,943 | -2.4% | 0.00% | – |
Q4 2017 | $237,000 | -39.1% | 118,846 | -0.9% | 0.00% | – |
Q3 2017 | $389,000 | -0.8% | 119,903 | -1.4% | 0.00% | – |
Q2 2017 | $392,000 | +1351.9% | 121,633 | +1188.2% | 0.00% | – |
Q1 2017 | $27,000 | +800.0% | 9,442 | +717.5% | 0.00% | – |
Q4 2016 | $3,000 | +50.0% | 1,155 | 0.0% | 0.00% | – |
Q3 2016 | $2,000 | +100.0% | 1,155 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | -98.9% | 1,155 | -98.9% | 0.00% | – |
Q1 2016 | $92,000 | -27.0% | 107,361 | +2.8% | 0.00% | – |
Q4 2015 | $126,000 | -28.8% | 104,390 | +0.3% | 0.00% | – |
Q3 2015 | $177,000 | -16.9% | 104,090 | +2.0% | 0.00% | – |
Q2 2015 | $213,000 | -5.3% | 102,062 | +22.7% | 0.00% | – |
Q1 2015 | $225,000 | +9.2% | 83,189 | +3.9% | 0.00% | – |
Q4 2014 | $206,000 | +40.1% | 80,084 | -0.6% | 0.00% | – |
Q3 2014 | $147,000 | -29.0% | 80,568 | +4.0% | 0.00% | – |
Q2 2014 | $207,000 | -33.0% | 77,498 | -12.2% | 0.00% | – |
Q1 2014 | $309,000 | -22.6% | 88,254 | -0.9% | 0.00% | -100.0% |
Q4 2013 | $399,000 | +5.8% | 89,039 | -4.3% | 0.00% | 0.0% |
Q3 2013 | $377,000 | -6.0% | 92,997 | -3.5% | 0.00% | 0.0% |
Q2 2013 | $401,000 | – | 96,413 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 500,000 | $2,055,000 | 4.58% |
Centric Wealth Management | 3,337,449 | $13,717,000 | 3.92% |
Sargent Investment Group, LLC | 3,599,580 | $14,794,000 | 3.90% |
Rubric Capital Management LP | 8,722,647 | $35,850,000 | 2.09% |
PERKINS CAPITAL MANAGEMENT INC | 542,283 | $2,229,000 | 1.29% |
ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $7,809,000 | 1.17% |
Venator Capital Management Ltd. | 550,000 | $2,624,000 | 0.89% |
LEVEL FOUR FINANCIAL, LLC | 120,000 | $493,000 | 0.23% |
ALGERT GLOBAL LLC | 147,616 | $607,000 | 0.19% |
Brown Advisory Securities, LLC | 275,000 | $1,130,000 | 0.19% |